Important message: Due to recent site outage we are still restoring full functionality to Authorea powered sites. Please bear with us until full functionality is restored

loading page

Validation of the Cell Cycle Arrest Biomarkers in the Diagnosis of Pregnancy Related Acute Kidney Injury
  • +3
  • osama el-minshawy,
  • mahmoud khedr,
  • ayman elsayed,
  • Moustafa Abu-Ella,
  • Fatma Kamel,
  • hesham keryakos
osama el-minshawy
Minia University Faculty of Medicine

Corresponding Author:[email protected]

Author Profile
mahmoud khedr
Minia University Faculty of Medicine
Author Profile
ayman elsayed
Minia University Faculty of Medicine
Author Profile
Moustafa Abu-Ella
Minia University Faculty of Medicine
Author Profile
Fatma Kamel
Minia University Faculty of Medicine
Author Profile
hesham keryakos
Minia University Faculty of Medicine
Author Profile

Abstract

Background: Pregnancy related acute kidney injury (PRAKI) is still a common serious problem in developing countries. Insulin-like growth factor-binding protein 7 (IGFBP7) and tissue inhibitor metalloproteinases-2 (TIMP-2) can identify critically ill patients at risk for the development of severe AKI. Objectives: To identify main causes and timing of PRAKI and to study the G1 cell cycle arrest biomarkers in cases diagnosed with (PRAKI) as a diagnostic tool. Methods: 80 pregnant women diagnosed with PRAKI were recruited from a single hospital as well as 30 age-matched pregnant women with normal pregnancy participated in this study. A urine specimen was collected from all study participants with established AKI within 24 hours of ICU admission to measure IGFBP7*TIMP-2. Results: The incidence of PRAKI was 1.1%. The most common cause of PRAKI is preeclampsia/eclampsia spectrum (61%). Most of the cases occur in the third trimester (60%) and postpartum period (23%). At a cutoff 0.33 ng/mL, the estimated sensitivity and specificity of urinary [TIMP-2]*[IGFBP7] in predicting PRAKI is 100% (95% CI) with NPV and PPV are 100%. Conclusions: Urinary [TIMP-2]*[IGFBP7] serves as a sensitive and specific biomarker in the diagnosis of PRAKI.